Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE

IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE

Basic information Safety Supplier Related

IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE Basic information

Product Name:
IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE
Synonyms:
  • imidazo[3,2-a]pyridine-3-carbaldehyde
  • IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE
  • IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE
  • [1,2-α]PYRIDIN-3-CARBOXALDEHYDE
  • Imidazo[1,2-a]pyridine-3-carbaldehyde
  • Imidazo[1,2-a]pyridine-3-carbaldehyde AldrichCPR
  • 3-imidazo[3,2-a]pyridinecarboxaldehyde
  • Imidazo[1,2-a]pyridine-3-carboxaldehyde (7CI, 8CI, 9CI, ACI)
CAS:
6188-43-8
MF:
C8H6N2O
MW:
146.15
Product Categories:
  • blocks
  • Imidazoles
  • Pyridines
Mol File:
6188-43-8.mol
More
Less

IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE Chemical Properties

Melting point:
127-129 °C
Density 
1.24±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
4.15±0.50(Predicted)
Appearance
Off-white to light yellow Solid
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
HazardClass 
IRRITANT
HS Code 
2933998090
More
Less

IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDE Usage And Synthesis

Synthesis

274-76-0

68-12-2

6188-43-8

Freshly distilled phosphorus trichloride (61 mL, 0.65 mol) was slowly added to N,N-dimethylformamide (120 mL, 1.55 mol) at 2 °C. After controlling the reaction temperature to gradually increase to room temperature, the reaction system was again cooled to 2 °C. Subsequently, a solution of N,N-dimethylformamide (60 mL) of imidazo[1,2-a]pyridine (10 g, 0.085 mol) was added dropwise. The reaction mixture was slowly warmed to 105 °C, followed by further warming to 140 °C. The reaction temperature was stabilized at 120 °C by removing the oil bath. Heating was continued at this temperature for 45 minutes, after which the temperature was reduced to 85 °C and continued for 2.5 hours. Upon completion of the reaction, the mixture was cooled and poured into ice-cooled 5% hydrochloric acid (600 mL) and the pH was adjusted with 20% sodium hydroxide solution to 9. The resulting solution was extracted with dichloromethane (1200 mL) overnight. The organic layer was separated, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to remove the solvent. The crude product was washed with water (5 x 15 mL) and dried again to give 3.49 g of imidazo[1,2-a]pyridine-3-carbaldehyde in 31% yield.

References

[1] Farmaco, Edizione Scientifica, 1981, vol. 36, # 12, p. 994 - 1003
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 9, p. 3454 - 3464
[3] European Journal of Medicinal Chemistry, 2011, vol. 46, # 10, p. 4820 - 4826
[4] Journal of Medicinal Chemistry, 1996, vol. 39, # 14, p. 2856 - 2859
[5] Patent: WO2005/66132, 2005, A1. Location in patent: Page/Page column 89-90

IMIDAZO[1,2-A]PYRIDIN-3-CARBOXALDEHYDESupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Shanghai Ennopharm Co., Ltd.
Tel
+86 (21) 6435-5022
Shanghai Aobo pharmaceutical Technology Co., Ltd
Tel
86-21-51320499
Email
aobo@aobopharm.com